BiosanaPharma

​

3C PROCESS

NEWS

ABOUT US

PRODUCT DEVELOPMENT

FORMULATION DEVELOPMENT

“We are a technology and product development company, passionate to improve affordability and accessibility of monoclonal antibodies”

Ard Tijsterman, CEO